Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre-Antoine Soret

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
La Revue Du Praticien|January 23, 2026
[Low phospholipidassociated cholelithiasis syndrome]Pierre-Antoine Soret, Olivier Chazouillères, Christophe Corpechot
La Revue Du Praticien|February 11, 2022
[Primary biliary cholangitis]Pierre-Antoine Soret, Olivier Chazouillères, Christophe Corpechot
Current Opinion in Gastroenterology|January 9, 2025
Current approach to diagnosis and management of low-phospholipid associated cholelithiasis syndromePierre-Antoine Soret, Olivier Chazouillères, Christophe Corpechot
Journal of Clinical Medicine|December 30, 2020
In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical AppraisalPierre-Antoine Soret, Julie Magusto, Chantal Housset, et al.
Alimentary Pharmacology & Therapeutics|October 11, 2023
Obeticholic acid as a second-line treatment for low phospholipid-associated cholelithiasis syndromePierre-Antoine Soret, Sara Lemoinne, Maxime Mallet, et al.
Digestive Diseases and Sciences|April 19, 2025
Obeticholic Acid vs Fibrates as Second-Line Therapy for Primary Biliary Cholangitis: Systematic Review and Meta-AnalysisEliabe S Abreu, Pedro Henrique Reginato, Jorge Ferreira Jasmineiro Pitanga, et al.
The American Journal of Gastroenterology|July 14, 2025
PBC-HOPE: A Randomized Controlled Trial of Hypnosis and Psychoeducation in Women With Primary Biliary Cholangitis and FatigueAurélie Untas, Cécile Goffette, Cécile Flahault, et al.
JHEP Reports : Innovation in Hepatology|October 16, 2025
Epidemiology, comorbidities, treatments and outcomes of autoimmune liver diseases: A French nationwide studyChristophe Corpechot, Pierre Hornus, Mallory Cals, et al.
Iscience|October 7, 2022
The necroptosis-inducing pseudokinase mixed lineage kinase domain-like regulates the adipogenic differentiation of pre-adipocytesJulie Magusto, Carine Beaupère, Marta B Afonso, et al.
Seminars in Arthritis and Rheumatism|November 6, 2017
Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory chronic diseases in daily clinical practice: The experience of Cochin University Hospital, Paris, FranceJérôme Avouac, Anna Moltó, Vered Abitbol, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
La Revue Du Praticien|January 23, 2026
[Low phospholipidassociated cholelithiasis syndrome]Pierre-Antoine Soret, Olivier Chazouillères, Christophe Corpechot
La Revue Du Praticien|February 11, 2022
[Primary biliary cholangitis]Pierre-Antoine Soret, Olivier Chazouillères, Christophe Corpechot
Current Opinion in Gastroenterology|January 9, 2025
Current approach to diagnosis and management of low-phospholipid associated cholelithiasis syndromePierre-Antoine Soret, Olivier Chazouillères, Christophe Corpechot
Journal of Clinical Medicine|December 30, 2020
In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical AppraisalPierre-Antoine Soret, Julie Magusto, Chantal Housset, et al.
Alimentary Pharmacology & Therapeutics|October 11, 2023
Obeticholic acid as a second-line treatment for low phospholipid-associated cholelithiasis syndromePierre-Antoine Soret, Sara Lemoinne, Maxime Mallet, et al.
Digestive Diseases and Sciences|April 19, 2025
Obeticholic Acid vs Fibrates as Second-Line Therapy for Primary Biliary Cholangitis: Systematic Review and Meta-AnalysisEliabe S Abreu, Pedro Henrique Reginato, Jorge Ferreira Jasmineiro Pitanga, et al.
The American Journal of Gastroenterology|July 14, 2025
PBC-HOPE: A Randomized Controlled Trial of Hypnosis and Psychoeducation in Women With Primary Biliary Cholangitis and FatigueAurélie Untas, Cécile Goffette, Cécile Flahault, et al.
JHEP Reports : Innovation in Hepatology|October 16, 2025
Epidemiology, comorbidities, treatments and outcomes of autoimmune liver diseases: A French nationwide studyChristophe Corpechot, Pierre Hornus, Mallory Cals, et al.
Iscience|October 7, 2022
The necroptosis-inducing pseudokinase mixed lineage kinase domain-like regulates the adipogenic differentiation of pre-adipocytesJulie Magusto, Carine Beaupère, Marta B Afonso, et al.
Seminars in Arthritis and Rheumatism|November 6, 2017
Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory chronic diseases in daily clinical practice: The experience of Cochin University Hospital, Paris, FranceJérôme Avouac, Anna Moltó, Vered Abitbol, et al.
Pageof 2